Kohtaro Yoshida
Overview
Explore the profile of Kohtaro Yoshida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, et al.
Am J Hypertens
. 2008 Apr;
21(5):576-81.
PMID: 18437150
Background: Recently, some investigators have shown that telmisartan, an angiotensin II (Ang II)-receptor blocker (ARB), is a partial agonist of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma). We investigate whether telmisartan improves...
2.
Ohno T, Kobayashi N, Yoshida K, Fukushima H, Matsuoka H
Am J Hypertens
. 2008 Jan;
21(2):224-30.
PMID: 18188157
Background: We have known that endothelial nitric-oxide synthase (eNOS) and oxidative stress may play a key role in cardiac performance in failing rat hearts. However, the interactions between eNOS or...
3.
Yoshida K, Kobayashi N, Ohno T, Fukushima H, Matsuoka H
J Hypertens
. 2007 Jul;
25(8):1633-42.
PMID: 17620960
Objectives: The interactions between eNOS or oxidative stress and bradykinin under long-term treatment of angiotensin II type 1 receptor antagonists (ATRA) remain unknown. To elucidate the molecular mechanisms of the...
4.
Nakano S, Kobayashi N, Yoshida K, Ohno T, Matsuoka H
Hypertens Res
. 2006 Mar;
28(11):925-36.
PMID: 16555582
Studies were performed to test the hypothesis that the angiotensin-converting enzyme (ACE)/epidermal growth factor receptor (EGFR)/extracellular signal-regulated kinases (ERK) pathway, nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase/lectin-like oxidized low-density lipoprotein receptor-1...
5.
Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, Tsubokou Y, et al.
Hypertension
. 2006 Mar;
47(4):671-9.
PMID: 16505212
Aldosterone may play a pivotal role in the pathophysiology of heart failure. To elucidate the beneficial cardioprotective mechanism of eplerenone, a novel selective aldosterone blocker, we hypothesized that eplerenone stimulates...
6.
Kobayashi N, Honda T, Yoshida K, Nakano S, Ohno T, Tsubokou Y, et al.
Atherosclerosis
. 2005 Oct;
187(1):92-100.
PMID: 16214149
To elucidate the molecular mechanisms of the cardioprotective effect of angiotensin-converting enzyme (ACE) inhibitors, we evaluated whether the effect of quinapril involved in bradykinin-endothelial nitric oxide synthase (eNOS) and oxidative...
7.
Kobayashi N, Hara K, Tojo A, Onozato M, Honda T, Yoshida K, et al.
Hypertension
. 2005 Feb;
45(4):538-44.
PMID: 15710785
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) may play an important role in atherosclerosis by inducing leukocyte adhesion molecules, such as intercellular and vascular cell adhesion molecule-1 (intercellular adhesion molecule-1 [ICAM-1],...
8.
Mita S, Kobayashi N, Yoshida K, Nakano S, Matsuoka H
J Hypertens
. 2005 Jan;
23(1):87-96.
PMID: 15643129
Objectives: Rho-kinase plays a crucial role in various cellular functions. To elucidate molecular mechanisms of Rho-kinase-mediated cardiovascular remodeling in vivo, we evaluated whether a signaling pathway through Rho is involved,...
9.
Kobayashi N, Yoshida K, Mita S, Honda T, Hara K, Nakano S, et al.
J Hypertens
. 2004 Jun;
22(7):1397-402.
PMID: 15201557
Objective: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and vascular endothelial growth factor (VEGF) may play key roles in atherosclerosis, and have been shown to regulate nitric oxide (NO) production. However,...
10.
Kobayashi N, Mita S, Yoshida K, Honda T, Kobayashi T, Hara K, et al.
Hypertension
. 2003 Oct;
42(5):1004-13.
PMID: 14557279
Vascular cell adhesion molecule-1 (VCAM-1) and reactive oxygen species play critical roles in early atherogenesis, and nitric oxide (NO) is an important regulator of the cardiovascular system. Although celiprolol, a...